Demonstration of antibodies against human malignant melanoma by immunofluorescence.
about
State of melanoma: an historic overview of a field in transition.Autoimmune reactions in uveal melanoma.Pathobiology of neoplasia. A teaching monograph.Progress of immunotherapy in the treatment of malignant melanoma.Clinical value of tumour-associated antigens.Current concepts in the management of carcinoma of the prostate gland.fTwo novel biomarkers, mesothelin and HE4, for diagnosis of ovarian carcinoma.Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cellsImmunochemical delineation of an oncofetal antigen on normal and simian virus 40-transformed human fetal melanocytesAdjuvant BCG immunotherapy for stage I and II malignant melanomaEighty years of immunotherapy: a review of immunological methods used for the treatment of human cancer.Foetal antigens and their role in the diagnosis and clinical management of human neoplasms: a review.Glioblastoma multiforme: a controlled trial to assess the value of specific active immunotherapy in patients treated by radical surgery and radiotherapy.Detection of anti-tumour cell mediated immunity and serum blocking factors in cancer patients by the leucocyte adherence inhibition test.The influence of tumour burden and therapy on cellular cytotoxicity responses in patients with ocular and skin melanoma.Detection of a low-molecular-weight antigen on melanoma cells by a human antiserum in leukocyte-dependent antibody assaysFurther characterization of a melanoma-specific protein from human urine.Stimulation of autologous blood lymphocytes by malignant lymphoma cells and homogenates.Circulating antibodies in human malignant diseaseCombinations of radiation therapy and immunotherapy for melanoma: a review of clinical outcomesCell surface antigens of human malignant melanoma. II. Serological typing with immune adherence assays and definition of two new surface antigensAntibody Therapeutics in Oncology.Lymphocyte depression by cancerStudies of humoral and cell-mediated immunity in human melanomaUsage of cancer associated autoantibodies in the detection of diseaseHuman melanoma cells have both nerve growth factor and nerve growth factor-specific receptors on their cell surfaces.Cell surface antigens of human melanoma identified by monoclonal antibody.Monoclonal antibody-directed effector cells selectively lyse human melanoma cells in vitro and in vivo.Effect of autoimmunization with irradiated tumour cells on specific cell-mediated immunity in patients with malignant melanoma.Tumour-associated antigens and tumour-host interactionsRegulation of CR3 (CD11b/CD18)-dependent natural killer (NK) cell cytotoxicity by tumour target cell MHC class I molecules.Interaction of human melanoma cell lines with autochthonous lymphoid cells.Immunological studies on malignant melanomas of man.Tumor-associated antigens in human malignant melanoma.Lymphoma-associated antigen (LAA): isolation, characterization and clinical evaluation.Melanoma vaccines and modulation of the immune system in the clinical setting: building from new realities.Immunological factors in human sarcomas and melanomas: a rational basis for immunotherapy.Tumour-specific antibodies in human malignant melanoma and their relationship to the extent of the disease.
P2860
Q33693906-C26CF580-8BAA-48A1-ACA2-694282970EBFQ33972290-7816EAC1-8D52-4DD0-8B1A-154A0911FE36Q34041048-D7B078A9-7554-485F-9BC1-30BD6EF56A16Q34085643-B190D724-F1F8-426F-938C-65AF11AEB010Q34303095-A4238F07-3D91-4D55-93C7-944634A596FBQ34830471-150846E7-BC96-40C3-A071-FE5F8C05B9F7Q35021181-5C31AAF4-F7CE-4BE1-A426-6F1F1D43B5CBQ35025264-87C79B0B-FD87-4E48-8F73-5C23E7198E85Q35386061-4A2531A8-5DF0-48BA-879B-28DF08DAF55DQ35805246-EE95C66E-662C-4DC4-B72E-D1000BC48943Q36038798-9DA4D950-2266-445C-A258-948DFE9F2F61Q36039439-DEA7AD8F-B52E-440F-B9B3-D2707848AC81Q36039846-6FC52E64-3D52-4858-A6D7-68AD2B23F18CQ36040820-959DE90E-C687-491D-8DC5-81A66066B092Q36041637-B8967274-3A3A-4E13-8214-0F1B9CAD53B0Q36043494-811C2DA1-77C3-4EA7-8D6D-60986863A721Q36043973-C6CF11AD-6D92-4EA2-861B-7628F094F03BQ36068882-95F7C42A-820A-486B-895B-99DF80F9EEA1Q36290170-EB90E908-C53A-4831-95C4-CFAD2D53944AQ36340598-FEAA6B9B-9CEA-4EE8-9832-FC4AB001FF6FQ36359942-847045A7-8547-4AE9-B404-4290CC336169Q36791878-8FC2CCC4-CD32-4367-986C-8AF03F806C07Q36801147-16AFF72B-C637-4470-A3A0-EA47031FD255Q36991945-67204E1A-B4C0-4216-987F-2F41279C0059Q37217734-C0BEA903-742E-4E31-A514-F291BD8160FAQ37320889-A86AD3AF-8FF9-4BFA-BC01-EA351121358DQ37334041-53AA63D7-A2FC-41B3-AF2B-4681EA3E3777Q37348039-A4845805-5B4B-4E2A-B9E7-3EDBC444D2BCQ39372511-69FC52DD-D860-462D-91DB-8F5C5EFC947CQ39895336-E62D4A7F-40EE-4B55-9B1A-F9EB905DF503Q40975346-7CF687A3-0028-4DE5-8704-8AED5DF93A05Q41447123-172DAD6F-91B8-435F-88C3-6E54F9FB0147Q41447653-DAD433F0-63B5-406B-8E61-2054E678D40FQ41448711-C6D0ED46-BBD6-428D-BE8E-35BBE1F96446Q41512542-C6BE20FF-2A8E-4DD3-BDC3-3AB48C7129B9Q42145973-1418FD7F-5E6D-4D83-A53C-5CD18F68B860Q46822132-DEF43043-88FD-4797-9E2B-F9A75AD662FEQ49205029-A77B49D3-E483-4EF2-8E03-C52EE892698F
P2860
Demonstration of antibodies against human malignant melanoma by immunofluorescence.
description
1968 nî lūn-bûn
@nan
1968年の論文
@ja
1968年学术文章
@wuu
1968年学术文章
@zh-cn
1968年学术文章
@zh-hans
1968年学术文章
@zh-my
1968年学术文章
@zh-sg
1968年學術文章
@yue
1968年學術文章
@zh
1968年學術文章
@zh-hant
name
Demonstration of antibodies against human malignant melanoma by immunofluorescence.
@en
Demonstration of antibodies against human malignant melanoma by immunofluorescence.
@nl
type
label
Demonstration of antibodies against human malignant melanoma by immunofluorescence.
@en
Demonstration of antibodies against human malignant melanoma by immunofluorescence.
@nl
prefLabel
Demonstration of antibodies against human malignant melanoma by immunofluorescence.
@en
Demonstration of antibodies against human malignant melanoma by immunofluorescence.
@nl
P2093
P1433
P1476
Demonstration of antibodies against human malignant melanoma by immunofluorescence
@en
P2093
Ketcham AS
Malmgren RA
P304
P407
P577
1968-07-01T00:00:00Z